Enterprise League logo

Product

CAR-T Cell Therapy

BIOTECHNOLOGY

byImmuneCyte, Inc.

United States (US)

ABOUT THE PRODUCT

ImmuneCyte is developing a next-generation CAR-T cell therapy platform targeting various cancers. This innovative approach utilizes enhanced T-cell engineering to improve efficacy and reduce side effects.

Information is owner-confirmed

Last updated 2 weeks ago

Price range
N/A

Other products/services from ImmuneCyte, Inc.

Default Product Image
CAR-NK Cell Therapy
Biotechnology

N/A

ImmuneCyte, Inc. Logo

ImmuneCyte, Inc.

United States (US)